JP Morgan Maintains Overweight on Septerna, Raises Price Target to $48

Benzinga · 1d ago
JP Morgan analyst Tessa Romero maintains Septerna (NASDAQ:SEPN) with a Overweight and raises the price target from $38 to $48.